Author | Christin Melton, ELS | OncLive

Author | Christin Melton, ELS


Bounty of New HCC Therapies Spurs Need for More Research

May 10, 2019

The optimal integration of new drugs into the treatment paradigm of HCC requires several key developments, including greater research into biomarkers that would help inform therapy choices, earlier treatment for patients diagnosed with HCC, and clinical trials that test combination strategies.

Novel Agents Ease Chemotherapy Burden in ALL, But Treating Older Patients Remains a Challenge

March 19, 2019

Immune-based approaches have revolutionized the treatment of acute lymphoblastic lymphoma, especially for patients unable to tolerate multiagent chemotherapy. Now, investigators are looking forward to seeing these agents move into frontline settings, perhaps leading to chemotherapy-free approaches.

Practical Treatment Questions Surface in HR-Positive Metastatic Breast Cancer

March 07, 2019

Novel and emerging agents are creating exciting new options for patients with hormone receptor–positive metastatic breast cancer, resulting in the need to consider how best to introduce and sequence these agents into the treatment timeline.

Progress and Challenges Mark the Myelofibrosis Landscape

December 12, 2018

A growing understanding about the underlying biology of myelofibrosis has helped improve the diagnosis and treatment of the disease during the past decade and is paving the way for further advancements.